Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.

TitleRisperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
Publication TypeJournal Article
Year of Publication2005
AuthorsMcDougle, CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold EL, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B
JournalThe American journal of psychiatry
Volume162
Issue6
Pagination1142-8
Date Published2005 Jun
ISSN0002-953X
KeywordsAdolescent, Antipsychotic Agents, Autistic Disorder, Child, Communication Disorders, Conduct Disorder, Double-Blind Method, Female, Humans, Interpersonal Relations, Male, Personality Inventory, Placebos, Psychiatric Status Rating Scales, Risperidone, Stereotyped Behavior, Stereotypic Movement Disorder, Treatment Outcome
Abstract

Risperidone has been found efficacious for decreasing severe tantrums, aggression, and self-injurious behavior in children and adolescents with autistic disorder (autism). The authors report on whether risperidone improves the core symptoms of autism, social and communication impairment and repetitive and stereotyped behavior.

DOI10.1016/j.comppsych.2011.05.003
Alternate JournalAm J Psychiatry